Preclinical use of a clinically-relevant scAAV9/SUMF1 vector for the treatment of multiple sulfatase deficiency
Abstract Background Multiple Sulfatase Deficiency (MSD) is a rare inherited lysosomal storage disorder characterized by loss of function mutations in the SUMF1 gene that manifests as a severe pediatric neurological disease. There are no available targeted therapies for MSD. Methods We engineered a v...
Saved in:
Main Authors: | Maximiliano Presa, Rachel M. Bailey, Somdatta Ray, Lauren Bailey, Saurabh Tata, Tara Murphy, Pierre-Alexandre Piec, Harold Combs, Steven J. Gray, Cathleen Lutz |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Communications Medicine |
Online Access: | https://doi.org/10.1038/s43856-025-00734-9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sulfatase modifying factor 2 as a predictive biomarker for urothelial carcinoma
by: Wei-Ting Kuo, et al.
Published: (2025-02-01) -
In vivo brain delivery of BBB-enabled iduronate 2-sulfatase in rats
by: Will J. Costain, et al.
Published: (2025-01-01) -
Systemic delivery of AAV5, AAV8, and AAV9 packaging a C5-12-microdystrophin-FLAG expression cassette in non-human primates
by: Mengping Liu, et al.
Published: (2025-03-01) -
Multiple Sulfatase Deficiency (MSD): Review of the Literature and Case Reports of Two Siblings with Dental Caries and Trauma
by: Lorna Hirst, et al.
Published: (2021-01-01) -
Inhibition of Steroid Sulfatase Activity in Endometriotic Implants by STX64 (667Coumate): A Potential New Therapy
by: L. Fusi, et al.
Published: (2008-01-01)